NAFUBI [Ibuprofen PharmSol]

Medicinal product

(Invented) name

NAFUBI [Ibuprofen PharmSol]

Active substance (s)

Ibuprofenas

Strength

200 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Nereceptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

M01AE01, Ibuprofen

Marketing authorisation holder

Pharmsol Europe Limited, Malta

Date of authorisation

2025-11-13

Date of renewal

Documents

5880_5881 Pakuotės lapelis 2026 02 02.docx

Ibuprofen PharmSol 200 400 600 mg pl dengt tab_viešas AR.pdf

5880_5881 NAFUBI 200,400 RPP 2026 02 02.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Ibuprofenas	200 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
119086	105191	1105191	lizdinė plokštelė	N10		Nereceptinis	LT/1/25/5880/001	Netiekiama	-	-	No	-	-
119087	105192	1105192	lizdinė plokštelė	N12		Nereceptinis	LT/1/25/5880/002	Netiekiama	-	-	No	-	-
119088	105193	1105193	lizdinė plokštelė	N14		Nereceptinis	LT/1/25/5880/003	Netiekiama	-	-	No	-	-
119089	105194	1105194	lizdinė plokštelė	N20		Nereceptinis	LT/1/25/5880/004	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2025-11-13	Registruotas